Overall, a number of previous observations as well as some more recent evidence emphasize the significance of TrkB as a valuable target for antidepressants [23,24] and reaffirm the critical role of BDNF/TrkB signaling in the pathophysiology of depression and in antidepressants action [7,25,26]. This evidence concerns the gene BDNF and depressive disorder.